Alps Group Inc (ALPS) vs Xilio Therapeutics, Inc. (XLO)
A side-by-side comparison of Alps Group Inc and Xilio Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALPS
Alps Group Inc
$0.38HealthcareDelayed quote: Oct 6, 2026, 3:19 PM EDT
XLO
Xilio Therapeutics, Inc.
$9.20HealthcareDelayed quote: Oct 6, 2026, 3:07 PM EDT
Total return — ALPS vs XLO
growth of $100 · dividends reinvested · last 1yALPS -96.7% (-96.7%/yr)XLO -21.7% (-21.7%/yr)XLO compounded faster over this window
Log scale — wide-divergence pair
ALPS XLO
ALPS vs XLO: by the numbers
- •ALPS is the larger company ($64M vs $60M market cap).
- •Both run net losses; XLO's is the smaller (-34.06% vs -41.36% net margin).
Metrics side by side
Valuation
| Metric | ALPS | XLO |
|---|---|---|
| P/S ratio | N/A | 0.94 |
| P/B ratio | N/A | 0.84 |
Profitability
| Metric | ALPS | XLO |
|---|---|---|
| Gross margin | 32.09% | 99.46% |
| Operating margin | -69.62% | -95.92% |
| Net margin | -41.36% | -34.06% |
| ROE | N/A | -30.21% |
| ROIC | N/A | -26.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.